Collectively, these findings position SIRT1 at the intersection of multiple pathological pathways in long COVID‐19, offering a promising molecular target for therapeutic intervention that could simultaneously address the vascular, immunological, and neurological sequelae of this complex condition. Here, SIRT1 is linked to COVID-19.